Solution NMR structure of the C-terminal domain of the human protein DEK

Protein Science

Volumn 13, Issue 8, 2004, Pages 2252-2259

  Devany, Matthew ^a   Kotharu, N Prasad ^a   Matsuo, Hiroshi ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Acute myeloid leukemia; Ataxia telangiectasia; Chromatin associated protein; Chromosomal translocation; NMR structure; Oncogene product

Indexed keywords

DNA; HYBRID PROTEIN; MUTAGENIC AGENT; PROTEIN DEK; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; ATAXIA TELANGIECTASIA; AUTOIMMUNE DISEASE; CANCER; CARBOXY TERMINAL SEQUENCE; FIBROBLAST; HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; STRUCTURE ANALYSIS;

ATAXIA TELANGIECTASIA; AUTOIMMUNE DISEASES; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA; FIBROBLASTS; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MUTAGENESIS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; ONCOGENE PROTEINS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; STRUCTURAL HOMOLOGY, PROTEIN; TRANSCRIPTION FACTORS;

ATAXIA; ATAXIA TELANGIECTASIA;

EID: 3342880687     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1110/ps.04797104     Document Type: Article

References (48)

1. Adams, B.S., Cha, H.C., Cleary, J., Haiying, T., Wang, H., Sitwala, K., and Markovitz, D.M. 2003. DEK binding to class II MHC Y-box sequences is gene- and allele-specific. Arthritis Res. Ther. 5: R226-R233.
2. Alexiadis, V., Waldmann, T., Andersen, J., Mann, M., Knippers, R., and Gruss, C. 2000. The protein encoded by the proto-oncogene DEK changes the topology of chromatin and reduces the efficiency of DNA replication in a chromatin-specific manner. Genes & Dev. 14: 1308-1312.
3. Anderson, M.J., Viars, C.S., Czekay, S., Cavenee, W.K., and Arden, K.C. 1998. Cloning and characterization of three human forkhead genes that comprise an FKHR-like gene subfamily. Genomics 47: 187-199.
4. Bartels, C., Xia, T.-H., Billeter, M., Güntert, P., and Wüthrich, K. 1995. The program XEASY for computer-supported NMR spectral analysis of biological macromolecules. J. Biomol. NMR 6: 1-10.
5. Bax, A., Clore, G.M., and Gronenborn, A.M. 1990. 1H-1H correlation via isotropic mixing of 13C magnetization: A new three-dimensional approach for assigning 1H and 13C spectra of 13C-enriched proteins. J. Magn. Reson. 88: 425-431.
6. Biggs 3rd, W.H., Cavenee, W.K., and Arden, K.C. 2001. Identification and characterization of members of the FKHR (FOX O) subclass of winged-helix transcription factors in the mouse. Mamm. Genome 12: 416-425.
7. Brunger, A.T. 1993. XPLOR Version 3.1: A system for X-ray crystallography and NMR. Yale University Press, New Haven, CT.
8. Carlsson, P. and Mahlapuu, M. 2002. Forkhead transcription factors: Key players in development and metabolism. Dev. Biol. 250: 1-23.
9. Clark, K.L., Halay, E.D., Lai, E., and Burley, S.K. 1993. Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5. Nature 364: 412-420.
10. Comilescu, G., Delaglio, F., and Bax, A. 1999. Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J. Biomol. NMR 13: 289-302.
11. Costa, R.H., Grayson, D.R., and Darnell Jr., J.E. 1989. Multiple hepatocyte-enriched nuclear factors function in the regulation of transthyretin and α 1-antitrypsin genes. Mol. Cell. Biol. 9: 1415-1425.
12. Delaglio, F., Grzesiek, S., Vuister, G.W., Zhu, G., Pfeifer, J., and Bax, A. 1995. NMRPipe: A multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6: 277-293.
13. Dong, X., Wang, J., Kabir, F.N., Shaw, M., Reed, A.M., Stein, L., Andrade, L.E., Trevisani, V.F., Miller, M.L., Fujii, T., et al. 2000. Autoantibodies to DEK oncoprotein in human inflammatory disease. Arthritis Rheum. 43: 85-93.
14. Fesik, S.W., Gampe, R.T.J., Zuiderweg, E.R., Kohlbrenner, W.E., and Weigl, D. 1989. Heteronuclear three-dimensional NMR spectroscopy applied to CMP-KDO synthetase (27.5 kD). Biochem. Biophys. Res. Commun. 159: 842-847.
15. Fu, G.K. and Markovitz, D.M. 1996. Purification of the pets factor. A nuclear protein that binds to the inducible TG-rich element of the human immunodeficiency virus type 2 enhancer. J. Biol. Chem. 271: 19599-19605.
16. Gajiwala, K.S. and Burley, S.K. 2000. Winged helix proteins. Curr. Opin. Struct. Biol. 10: 110-116.
17. Grottke, C., Mantwill, K., Dietel, M., Schadendorf, D., and Lage, H. 2000. Identification of differentially expressed genes in human melanoma cells with acquired resistance to various antineoplastic drugs. Int. J. Cancer 88: 535-546.
18. Grzesiek, S. and Bax, A. 1992a. Correlating backbone amide and side chain resonances in large proteins by multiple relayed triple resonance NMR. J. Am. Chem. Soc. 114: 6291-6293.
19. -. 1992b. An efficient experiment for sequential backbone assignment of medium sized isotopically enriched proteins. J. Magn. Reson. 99: 201-207.
20. Hannibal, M.C., Markovitz, D.M., and Nabel, G.J. 1994. Multiple cis-acting elements in the human immunodeficiency virus type 2 enhancer mediate the response to T-cell receptor stimulation by antigen in a T-cell hybridoma line. Blood 83: 1839-1846.
21. Helin, K. 1998. Regulation of cell proliferation by the E2F transcription factors. Curr. Opin. Genet. Dev. 8: 28-35.
22. Holm, L. and Park, J. 2000. DaliLite workbench for protein structure comparison. Bioinformatics 16: 566-567.
23. Jin, C., Marsden, I., Chen, X., and Liao, X. 1999. Dynamic DNA contacts observed in the NMR structure of winged helix protein-DNA complex. J. Mol. Biol. 289: 683-690.
24. Kondoh, N., Wakatsuki, T., Ryo, A., Hada, A., Aihara, T., Horiuchi, S., Goseki, N., Matsubara, O., Takenaka, K., Shichita, M., et al. 1999. Identification and characterization of genes associated with human hepatocellular carcinogenesis. Cancer Res. 59: 4990-4996.
25. Koradi, R., Billeter, M., and Wuthrich, K. 1996. MOLMOL: A program for display and analysis of macromolecular structures. J. Mol. Graph. 14: 51-55.
26. Krithivas, A., Fujimuro, M., Weidner, M., Young, D.B., and Hayward, S.D. 2002. Protein interactions targeting the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus to cell chromosomes. J. Virol. 76: 11596-11604.
27. Kroes, R.A., Jastrow, A., McLone, M.G., Yamamoto, H., Colley, P., Kersey, D.S., Yong, V.W., Mkrdichian, E., Cerullo, L., Leestma, J., et al. 2000. The identification of novel therapeutic targets for the treatment of malignant brain tumors. Cancer Lett. 156: 191-198.
28. Larramendy, M.L., Niini, T., Elonen, E., Nagy, B., Ollila, J., Vihinen, M., and Knuutila, S. 2002. Overexpression of translocation-associated fusion genes of FGFRI, MYC, NPMI, and DEK, but absence of the translocations in acute myeloid leukemia. A microarray analysis. Haematologica 87: 569-577.
29. Laskowski, R.A., Rullmannn, J.A., MacArthur, M.W., Kaptein, R., and Thornton, J.M. 1996. AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR. J. Biomol. NMR 8: 477-486.
30. 15N Hartmann-Hahn-multiple quantum coherence and nuclear Overhauser-multiple quantum coherence spectroscopy: Applied to interleukin 1β. Biochemistry 28: 6150-6156.
31. 15N-labeled proteins. J. Am. Chem. Soc. 111: 1515-1517.
32. Markovitz, D.M., Hannibal, M., Perez, V.L., Gauntt, C., Folks, T.M., and Nabel, G.J. 1990. Differential regulation of human immunodeficiency viruses (HIVs): A specific regulatory element in HIV-2 responds to stimulation of the T-cell antigen receptor. Proc. Natl. Acad. Sci. 87: 9098-9102.
33. Markovitz, D.M., Smith, M.J., Hilfinger, J., Hannibal, M.C., Petryniak, B., and Nabel, G.J. 1992. Activation of the human immunodeficiency virus type 2 enhancer is dependent on purine box and kappa B regulatory elements. J. Virol. 66: 5479-5484.
34. Meyn, M.S., Lu-Kuo, J.M., and Herzing, L.B. 1993. Expression cloning of multiple human cDNAs that complement the phenotypic defects of ataxia-telangiectasia group D fibroblasts. Am. J. Hum. Genet. 53: 1206-1216.
35. Nicholls, A., Sharp, K.A., and Honig, B. 1991. Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 11: 281-296.
36. Perkins, N.D., Edwards, N.L., Duckett, C.S., Agranoff, A.B., Schmid, R.M., and Nabel, G.J. 1993. A cooperative interaction between NF-κ B and Sp1 is required for HIV-1 enhancer activation. EMBO J. 12: 3551-3558.
37. Sheng, W., Rance, M., and Liao, X. 2002. Structure comparison of two conserved HNF-3/fkh proteins HFH-1 and genesis indicates the existence of folding differences in their complexes with a DNA binding sequence. Biochemistry 41: 3286-3293.
38. Siegrist, C.A., Durand, B., Emery, P., David, E., Hearing, P., Mach, B., and Reith, W. 1993. RFXI is identical to enhancer factor C and functions as a transactivator of the hepatitis B virus enhancer. Mol. Cell. Biol. 13: 6375-6384.
39. Sierakowska, H., Williams, K.R., Szer, I.S., and Szer, W. 1993. The putative oncoprotein DEK, part of a chimera protein associated with acute myeloid leukaemia, is an autoantigen in juvenile rheumatoid arthritis. Clin. Exp. Immunol. 94: 435-439.
40. Slansky, J.E. and Farnham, P.J. 1996. Introduction to the E2F family: Protein structure and gene regulation. Curr. Top. Microbiol. Immunol. 208: 1-30.
41. Solomon, I. 1955. Relaxation processes in a system of two spins. Physiol. Rev. 99: 559-565.
42. Sutton, J., Costa, R., Klug, M., Field, L., Xu, D., Largaespada, D.A., Fletcher, C.F., Jenkins, N.A., Copeland, N.G., Klemsz, M., et al. 1996. Genesis, a winged helix transcriptional repressor with expression restricted to embryonic stem cells. J. Biol. Chem. 271: 23126-23133.
43. Szer, W., Sierakowska, H., and Szer, I.S. 1991. Antinuclear antibody profile in juvenile rheumatoid arthritis. J. Rheumatol. 18: 401-408.
44. Szer, I.S., Sierakowska, H., and Szer, W. 1994. A novel autoantibody to the putative oncoprotein DEK in pauciarticular onset juvenile rheumatoid arthritis. J. Rheumatol. 21: 2136-2142.
45. von Lindern, M., Fomerod, M., Soekarman, N., van Baal, S., Jaegle, M., Hagemeijer, A., Bootsma, D., and Grosveld, G. 1992. Translocation t(6;9) in acute non-lymphocytic leukaemia results in the formation of a DEK-CAN fusion gene. Baillieres Clin. Haematol. 5: 857-879.
46. Weigel, D., Jurgens, G., Kuttner, F., Seifert, E., and Jackle, H. 1989. The homeotic gene fork head encodes a nuclear protein and is expressed in the terminal regions of the Drosophila embryo. Cell 57: 645-658.
47. Weigelt, J., Climent, I., Dahlman-Wright, K., and Wikstrom, M. 2001. Solution structure of the DNA binding domain of the human forkhead transcription factor AFX (FOXO4). Biochemistry 40: 5861-5869.
48. Zheng, N., Fraenkel, E., Pabo, C.O., and Pavletich, N.P. 1999. Structural basis of DNA recognition by the heterodimeric cell cycle transcription factor E2F-DP. Genes & Dev. 13: 666-674.